Glaukos Corporation (NYSE:GKOS) just released its latest third-quarter results and things are looking bullish. Revenues and losses per share were both better than expected, with revenues of US$97m leading estimates by 5.7%. Statutory losses were smaller than the analystsexpected, coming in at US$0.39 per share. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

Check out our latest analysis for Glaukos

Following the latest results, Glaukos' 13 analysts are now forecasting revenues of US$473.1m in 2025. This would be a major 31% improvement in revenue compared to the last 12 months. Losses are predicted to fall substantially, shrinking 51% to US$1.34. Yet prior to the latest earnings, the analysts had been forecasting revenues of US$464.5m and losses of US$1.61 per share in 2025. Although the revenue estimates have not really changed Glaukos'future looks a little different to the past, with a favorable reduction in the loss per share forecasts in particular.

The average price target held steady at US$140, seeming to indicate that business is performing in line with expectations. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Glaukos, with the most bullish analyst valuing it at US$155 and the most bearish at US$115 per share. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Glaukos is an easy business to forecast or the the analysts are all using similar assumptions.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. It's clear from the latest estimates that Glaukos' rate of growth is expected to accelerate meaningfully, with the forecast 24% annualised revenue growth to the end of 2025 noticeably faster than its historical growth of 8.9% p.a. over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 8.2% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Glaukos to grow faster than the wider industry.

The Bottom Line

The most important thing to take away is that the analysts reconfirmed their loss per share estimates for next year. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. The consensus price target held steady at US$140, with the latest estimates not enough to have an impact on their price targets.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At Simply Wall St, we have a full range of analyst estimates for Glaukos going out to 2026, and you can see them free on our platform here..

Even so, be aware that Glaukos is showing 2 warning signs in our investment analysis , you should know about...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.